Therefore, we studied the roles of DCIR in OC differentiation and resorptive activity using a mouse model of osteoporosis involving intraperitoneal injection of modified RANKL (glutathione-S-transferase (GST)-fused RANKL) (Figure 3A). Here, HPGDS is linked to osteoporosis.